Who owns MATINAS BIOPHARMA HLDGS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Matinas Biopharma Hldgs with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Matinas Biopharma Hldgs stock

Who bought or sold MATINAS BIOPHARMA HLDGS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Vanguard Group 60k $113k 0% Sep 2025
 View chart
Geode Capital Management 56k $106k 1% Sep 2025
 View chart
BlackRock 50k $94k 0% Sep 2025
 View chart
Sargent Investment Group 37k $69k 3% Sep 2025
 View chart
Holos Integrated Wealth 33k $37k 100% Jun 2025
 View chart
Renaissance Technologies 28k $53k 15% Sep 2025
 View chart
Northern Trust 23k $43k 100% Sep 2025
 View chart
State Street Corporation 15k $29k 0% Sep 2025
 View chart
Two Sigma Securities 13k $24k 100% Sep 2025
 View chart
Hrt Financial 11k $20k 100% Sep 2025
 View chart
Tower Research Capital 1.4k $2.7k 31% Sep 2025
 View chart
Rockefeller Capital Management 500.00 $945.000000 100% Sep 2025
 View chart
Farther Finance Advisors 422.00 $798.002000 8340% Sep 2025
 View chart
Advisor Group Holdings 210.00 $394.002000 0% Sep 2025
 View chart
UBS Group 200.00 $378.000000 82% Sep 2025
 View chart
Costello Asset Management 200.00 $378.000000 0% Sep 2025
 View chart
Morgan Stanley 144.00 $128.001600 100% Jun 2025
 View chart
Wells Fargo & Company 102.00 $193.004400 0% Sep 2025
 View chart
Steward Partners Investment Advisory 61.00 $114.997200 0% Sep 2025
 View chart
EverSource Wealth Advisors 60.00 $112.998000 0% Sep 2025
 View chart
Jones Financial Companies, L.L 60.00 $114.000000 0% Sep 2025
 View chart
Vision Financial Markets 40.00 $76.000000 0% Sep 2025
 View chart
Rothschild Investment 14.00 $25.999400 0% Sep 2025
 View chart
SBI Securities 11.00 $21.000100 0% Sep 2025
 View chart
FMR 5.00 $9.000000 150% Sep 2025
 View chart
MAI Wealth Advisors 2.00 $4.000000 0% Sep 2025
 View chart

Who sold out of Matinas Biopharma Hldgs?

Fund or Company Name Date Sold Shares Held Valued At
Jpmorgan Chase & Co Mar 2025 904.00 $470.080000
Raymond James Financial Jun 2025 320.00 $284.992000